Indivior PLC (LON:INDV)
1,015.00
+26.50 (2.68%)
Jun 6, 2025, 4:35 PM BST
Indivior Revenue
Indivior had revenue of $266.00M USD in the quarter ending March 31, 2025, a decrease of -6.34%. This brings the company's revenue in the last twelve months to $1.17B, up 4.09% year-over-year. In the year 2024, Indivior had annual revenue of $1.19B with 8.69% growth.
Revenue (ttm)
$1.17B
Revenue Growth
+4.09%
P/S Ratio
1.40
Revenue / Employee
$1.11M
Employees
1,051
Market Cap
1.27B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 95.00M | 8.69% |
Dec 31, 2023 | 1.09B | 192.00M | 21.31% |
Dec 31, 2022 | 901.00M | 110.00M | 13.91% |
Dec 31, 2021 | 791.00M | 144.00M | 22.26% |
Dec 31, 2020 | 647.00M | -138.00M | -17.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Indivior News
- 5 days ago - Drugmaker Invidior to abandon London listing amid exodus of companies - The Guardian
- 5 days ago - Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - Seeking Alpha
- 5 days ago - Drug maker Indivior to abandon London stock market for the US - Evening Standard
- 5 days ago - Drug maker Indivior joins the flight from London share listings - Evening Standard
- 5 days ago - Indivior to delist from London Stock Exchange, maintain Nasdaq listing - Reuters
- 5 days ago - UK Stock Market News: Vodafone, Indivior, ME Group - The Armchair Trader
- 5 days ago - Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - PRNewsWire
- 11 days ago - Indivior Announces Patrick Barry as Chief Commercial Officer - PRNewsWire